Vault-13

Nextech Invest Ltd.

Zurich, V8 · CIK 1595430 · 13F filing filed 2026-08-14

Exempt reporting adviser since 2022 · other (specify)

As an employer

$2.1bn reported value +48.3% vs Q1 2026
15positions
98.0%in top 10
2 new 3 added 1 reduced 4 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 REVOLUTION MEDICINES INC COM RVMD RVMD 7,601,087 $1.4bn67.55% 67.55% UnchangedShares held: Q3 2025 7.6m, Q4 2025 7.6m, Q1 2026 7.6m, Q2 2026 7.6m
2 PARABILIS MEDICINES INC COM PBLS PBLS 4,663,176 $127.6m6.06% 6.06% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 4.7m
3 RELAY THERAPEUTICS INC COM RLAY RLAY 6,776,506 $126.8m6.02% 6.02% AddedShares held: Q3 2025 3.8m, Q4 2025 4.7m, Q1 2026 5.5m, Q2 2026 6.8m +1.2m +1,250,000 22.6%
4 TYRA BIOSCIENCES INC COM TYRA TYRA 3,553,585 $113.5m5.39% 5.39% ReducedShares held: Q3 2025 4.1m, Q4 2025 4.1m, Q1 2026 4.1m, Q2 2026 3.6m -502.3k -502,276 -12.4%
5 ALUMIS INC COM ALMS ALMS 3,540,998 $99.6m4.73% 4.73% UnchangedShares held: Q3 2025 2.9m, Q4 2025 2.9m, Q1 2026 3.5m, Q2 2026 3.5m
6 ORIC PHARMACEUTICALS INC COM ORIC ORIC 7,162,637 $77.6m3.68% 3.68% UnchangedShares held: Q3 2025 7.2m, Q4 2025 7.2m, Q1 2026 7.2m, Q2 2026 7.2m
7 KYMERA THERAPEUTICS INC COM KYMR KYMR 278,896 $32.0m1.52% 1.52% UnchangedShares held: Q3 2025 340.9k, Q4 2025 278.9k, Q1 2026 278.9k, Q2 2026 278.9k
8 ZYMEWORKS INC COM ZYME ZYME 1,113,946 $29.1m1.38% 1.38% UnchangedShares held: Q3 2025 1.1m, Q4 2025 1.1m, Q1 2026 1.1m, Q2 2026 1.1m
9 MONTE ROSA THERAPEUTICS INC COM GLUE GLUE 761,153 $18.4m0.87% 0.87% AddedShares held: Q3 2025 0, Q4 2025 279.2k, Q1 2026 304.2k, Q2 2026 761.2k +456.9k +456,916 150.2%
10 ARVINAS INC COM ARVN ARVN 1,122,713 $17.1m0.81% 0.81% AddedShares held: Q3 2025 1.4m, Q4 2025 539.4k, Q1 2026 539.4k, Q2 2026 1.1m +583.3k +583,319 108.1%
11 CYTOMX THERAPEUTICS INC COM CTMX CTMX 4,449,932 $16.7m0.79% 0.79% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 4.4m, Q2 2026 4.4m
12 SILENCE THERAPEUTICS PLC ADS SLN SLN 952,400 $10.5m0.50% 0.50% UnchangedShares held: Q3 2025 952.4k, Q4 2025 952.4k, Q1 2026 952.4k, Q2 2026 952.4k
13 CORVUS PHARMACEUTICALS INC COM CRVS CRVS 450,000 $6.7m0.32% 0.32% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 450.0k, Q2 2026 450.0k
14 CONTEXT THERAPEUTICS INC COM CNTX CNTX 7,419,355 $4.1m0.20% 0.20% UnchangedShares held: Q3 2025 7.4m, Q4 2025 7.4m, Q1 2026 7.4m, Q2 2026 7.4m
15 ENGENE THERAPEUTICS INC COM ENGN ENGN 2,324,943 $4.0m0.19% 0.19% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.3m

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
TANGO THERAPEUTICS INC TNGX TNGX 7,266,081 $152.0m7.3m shares
CULLINAN THERAPEUTICS INC CGEM CGEM 1,141,145 $16.2m1.1m shares
ENGENE HOLDINGS INC 2,324,943 $15.8m2.3m shares
ARS PHARMACEUTICALS INC SPRY SPRY 610,703 $4.9m610.7k shares